Literature DB >> 23054018

Effect of targeted silencing of hTERT mRNA by lentivirus-mediated siRNA on A549 lung cancer cells in vitro.

Haibo Tang1, Linhu Ge, Wenlong Shao, Yuan Qiu, Dong Cui.   

Abstract

In our present study, we took advantage of the characteristics of RNA interference technology, which can efficiently, stably, and specifically silence target genes, and designed a small interfering RNA (siRNA) that could specifically target hTERT mRNA. We used a lentiviral vector (LV) to deliver the hTERT siRNA into telomerase-positive A549 lung cancer cells and investigated the effect of hTERT siRNA on the hTERT mRNA levels, hTERT protein levels, cell proliferation, and apoptosis in the lung cancer cells. The results from quantitative PCR, Western blotting, and the MTT assay showed that the expression levels of both hTERT mRNA and protein in the cells were significantly decreased and that the cell proliferation rate started to significantly slow down at 48 h after transfection with hTERT-LV. Our study demonstrated that siRNA sequences specifically targeting hTERT mRNA, which were packaged into lentivirus particles and then used to transfect the lung cancer cell line A549, can specifically silence the mRNA of the target gene, hTERT, and then reduce the hTERT protein expression level, which, in turn, reduces cell proliferation, inhibits cell growth, and induces apoptosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23054018     DOI: 10.1007/s11033-012-2099-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  49 in total

Review 1.  RNA interference.

Authors:  Gregory J Hannon
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

2.  Functional characterization and developmental regulation of mouse telomerase RNA.

Authors:  M A Blasco; W Funk; B Villeponteau; C W Greider
Journal:  Science       Date:  1995-09-01       Impact factor: 47.728

3.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

4.  Active-specific immunotherapy for non-small cell lung cancer.

Authors:  Hauke Winter; Natasja K van den Engel; Margareta Rusan; Nina Schupp; Christian H Poehlein; Hong-Ming Hu; Rudolf A Hatz; Walter J Urba; Karl-Walter Jauch; Bernard A Fox; Dominik Rüttinger
Journal:  J Thorac Dis       Date:  2011-06       Impact factor: 2.895

5.  Reverse transcriptase inhibitors suppress telomerase function and induce senescence-like processes in cultured mouse fibroblasts.

Authors:  Y E Yegorov; D N Chernov; S S Akimov; N L Bolsheva; A A Krayevsky; A V Zelenin
Journal:  FEBS Lett       Date:  1996-07-01       Impact factor: 4.124

6.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

7.  Reconstitution of human telomerase activity in vitro.

Authors:  T L Beattie; W Zhou; M O Robinson; L Harrington
Journal:  Curr Biol       Date:  1998-01-29       Impact factor: 10.834

8.  Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes.

Authors:  T S Lendvay; D K Morris; J Sah; B Balasubramanian; V Lundblad
Journal:  Genetics       Date:  1996-12       Impact factor: 4.562

9.  Reverse transcriptase motifs in the catalytic subunit of telomerase.

Authors:  J Lingner; T R Hughes; A Shevchenko; M Mann; V Lundblad; T R Cech
Journal:  Science       Date:  1997-04-25       Impact factor: 47.728

10.  Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer.

Authors:  Diego Serrano; Anne-Marie Bleau; Ignacio Fernandez-Garcia; Tamara Fernandez-Marcelo; Pilar Iniesta; Carlos Ortiz-de-Solorzano; Alfonso Calvo
Journal:  Mol Cancer       Date:  2011-08-09       Impact factor: 27.401

View more
  2 in total

1.  shRNA-mediated silencing of hTERT suppresses proliferation and promotes apoptosis in osteosarcoma cells.

Authors:  P Chen; W-L Gu; M-Z Gong; J Wang; D-Q Li
Journal:  Cancer Gene Ther       Date:  2017-08-11       Impact factor: 5.987

2.  Effects of silencing Rab27a gene on biological characteristics and chemosensitivity of non-small cell lung cancer.

Authors:  Xia Li; Haiying Wang; Qinggan Ni; Zhiyuan Tang; Jun Ni; Liqin Xu; Hua Huang; Songshi Ni; Jian Feng
Journal:  Oncotarget       Date:  2017-10-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.